New measures in MD Snapshot-Prescribing: opioid-naïve patients

Read time: 1 minute

Your latest prescribing data will soon be available in MD Snapshot-Prescribing, and alongside personalized, up-to-date information on opioid, benzodiazepine and antibiotic prescribing, you will now see additional measures on patients who are opioid naïve.

Why opioid-naïve measures?

This new data can be used by physicians to minimize opioid-related risks such as misuse, overdose and opioid use disorder.

For the purposes of MD Snapshot-Prescribing, opioid-naïve patients are those who are prescribed opioids for acute pain, at initiation for chronic pain, and have no available history of opioid dispenses in the previous 180 days.

Does CPSA want physicians to stop prescribing opioids?

No. We trust physicians to make good clinical decisions in the best interest of their patients. The data provided in MD Snapshot-Prescribing is not punitive, but rather offers physicians an opportunity to optimize prescribing and provide informed, high-quality patient care.

Where can I access more information?

Prescribers will receive an email later this month when updated data is available in MD Snapshot-Prescribing. If you have any questions, or are looking for prescribing support, please email AIR.Inquiries@cpsa.ab.ca.